Anterra Capital
Anterra Capital is an Amsterdam-headquartered venture capital firm that invests in food, agricultural, health, nutrition, technology and wellness companies across Europe, North America, Asia Pacific and Latin America. Established in 2013, the firm focuses on growth-stage opportunities in the global food supply chain, supporting companies that are commercializing novel technologies and services. It acts as a lead investor, taking significant minority equity positions and engaging actively on portfolio company boards. Typical investments range from 1 million to 15 million euros, with a track record of helping portfolio companies raise additional capital from professional investors. Anterra Capital emphasizes long-term partnership with management teams to build lasting value while avoiding investments in funds, land, operating assets, or capital-intensive ventures. It aims to improve safety, efficiency and sustainability across the food supply chain by backing innovators across the sector.
Top Stages
https://crunchbase.com/organization/***
https://linkedin.com/company/***
https://signal.nfx.com/firms/***
Past deals in Pets
Dalma
Series B in 2025
Dalma is an animal insurance company focused on providing pet owners with transparent, subscription-based health insurance. The company’s platform is designed to be user-friendly, offering coverage that reimburses costs associated with illnesses, injuries, and preventive care for pets. In addition to financial support, Dalma also provides customers with free unlimited access to veterinary advice and tips, facilitating better care for their animals. Through its digital approach, Dalma aims to simplify the insurance process for pet owners and enhance their overall experience in managing their pets' health.
Dalma
Series B in 2024
Dalma is an animal insurance company focused on providing pet owners with transparent, subscription-based health insurance. The company’s platform is designed to be user-friendly, offering coverage that reimburses costs associated with illnesses, injuries, and preventive care for pets. In addition to financial support, Dalma also provides customers with free unlimited access to veterinary advice and tips, facilitating better care for their animals. Through its digital approach, Dalma aims to simplify the insurance process for pet owners and enhance their overall experience in managing their pets' health.
Animol Discovery
Series C in 2024
Animol specializes in developing proprietary veterinary small molecule drugs using its innovative technology platform. Led by industry experts, the company focuses on creating breakthrough medicines tailored to the specific needs of animal patients.
Animol Discovery
Series B in 2023
Animol specializes in developing proprietary veterinary small molecule drugs using its innovative technology platform. Led by industry experts, the company focuses on creating breakthrough medicines tailored to the specific needs of animal patients.
Dalma
Series A in 2023
Dalma is an animal insurance company focused on providing pet owners with transparent, subscription-based health insurance. The company’s platform is designed to be user-friendly, offering coverage that reimburses costs associated with illnesses, injuries, and preventive care for pets. In addition to financial support, Dalma also provides customers with free unlimited access to veterinary advice and tips, facilitating better care for their animals. Through its digital approach, Dalma aims to simplify the insurance process for pet owners and enhance their overall experience in managing their pets' health.
Animol Discovery
Series B in 2022
Animol specializes in developing proprietary veterinary small molecule drugs using its innovative technology platform. Led by industry experts, the company focuses on creating breakthrough medicines tailored to the specific needs of animal patients.
Dalma
Series A in 2022
Dalma is an animal insurance company focused on providing pet owners with transparent, subscription-based health insurance. The company’s platform is designed to be user-friendly, offering coverage that reimburses costs associated with illnesses, injuries, and preventive care for pets. In addition to financial support, Dalma also provides customers with free unlimited access to veterinary advice and tips, facilitating better care for their animals. Through its digital approach, Dalma aims to simplify the insurance process for pet owners and enhance their overall experience in managing their pets' health.
Invetx
Series B in 2022
Invetx, Inc. is a biotechnology company based in Boston, Massachusetts, specializing in the development of protein-based therapeutics for animal health care and veterinary medicine. The company employs a team of veterinary scientists and clinicians dedicated to the discovery and development of biotherapeutics for both pets and farm animals. Invetx aims to transform the animal health industry by leveraging biopharmaceutical technologies to improve health outcomes significantly. By combining deep expertise in veterinary science with innovative therapeutic solutions, Invetx seeks to advance the future of animal care, providing effective treatments that cater to the needs of various animal populations.
Invetx
Series A in 2020
Invetx, Inc. is a biotechnology company based in Boston, Massachusetts, specializing in the development of protein-based therapeutics for animal health care and veterinary medicine. The company employs a team of veterinary scientists and clinicians dedicated to the discovery and development of biotherapeutics for both pets and farm animals. Invetx aims to transform the animal health industry by leveraging biopharmaceutical technologies to improve health outcomes significantly. By combining deep expertise in veterinary science with innovative therapeutic solutions, Invetx seeks to advance the future of animal care, providing effective treatments that cater to the needs of various animal populations.
Invetx
Series A in 2020
Invetx, Inc. is a biotechnology company based in Boston, Massachusetts, specializing in the development of protein-based therapeutics for animal health care and veterinary medicine. The company employs a team of veterinary scientists and clinicians dedicated to the discovery and development of biotherapeutics for both pets and farm animals. Invetx aims to transform the animal health industry by leveraging biopharmaceutical technologies to improve health outcomes significantly. By combining deep expertise in veterinary science with innovative therapeutic solutions, Invetx seeks to advance the future of animal care, providing effective treatments that cater to the needs of various animal populations.
Animol Discovery
Series A in 2020
Animol specializes in developing proprietary veterinary small molecule drugs using its innovative technology platform. Led by industry experts, the company focuses on creating breakthrough medicines tailored to the specific needs of animal patients.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.